GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Syneos Health Inc (NAS:SYNH) » Definitions » Price-to-Free-Cash-Flow

Syneos Health (Syneos Health) Price-to-Free-Cash-Flow : 27.31 (As of May. 05, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Syneos Health Price-to-Free-Cash-Flow?

As of today (2024-05-05), Syneos Health's share price is $42.98. Syneos Health's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2023 was $1.57. Hence, Syneos Health's Price-to-Free-Cash-Flow Ratio for today is 27.31.

The historical rank and industry rank for Syneos Health's Price-to-Free-Cash-Flow or its related term are showing as below:

SYNH' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 8.54   Med: 20.99   Max: 127.24
Current: 25.54

During the past 12 years, Syneos Health's highest Price-to-Free-Cash-Flow Ratio was 127.24. The lowest was 8.54. And the median was 20.99.

SYNH's Price-to-Free-Cash-Flow is not ranked
in the Medical Diagnostics & Research industry.
Industry Median: 26.94 vs SYNH: 25.54

Syneos Health's Free Cash Flow per Share for the three months ended in Jun. 2023 was $-0.50. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was $1.57.

During the past 12 months, the average Free Cash Flow per Share Growth Rate of Syneos Health was -43.60% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was 11.70% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was 13.60% per year. During the past 10 years, the average Free Cash Flow per Share Growth Rate was 20.90% per year.

During the past 12 years, Syneos Health's highest 3-Year average Free Cash Flow per Share Growth Rate was 79.10% per year. The lowest was -9.30% per year. And the median was 17.25% per year.


Syneos Health Price-to-Free-Cash-Flow Historical Data

The historical data trend for Syneos Health's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Syneos Health Price-to-Free-Cash-Flow Chart

Syneos Health Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.97 23.84 18.45 27.01 11.21

Syneos Health Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24.15 13.82 11.21 12.14 24.65

Competitive Comparison of Syneos Health's Price-to-Free-Cash-Flow

For the Diagnostics & Research subindustry, Syneos Health's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Syneos Health's Price-to-Free-Cash-Flow Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Syneos Health's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Syneos Health's Price-to-Free-Cash-Flow falls into.



Syneos Health Price-to-Free-Cash-Flow Calculation

Syneos Health's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=42.98/1.574
=27.31

Syneos Health's Share Price of today is $42.98.
Syneos Health's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.57.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Syneos Health  (NAS:SYNH) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Syneos Health Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Syneos Health's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Syneos Health (Syneos Health) Business Description

Traded in Other Exchanges
N/A
Address
1030 Sync Street, Morrisville, NC, USA, 27560-5468
Syneos is a global contract research and outsourced commercialization organization that provides services to pharmaceutical and biotechnology firms. Its clinical solutions segment offers early- to late-stage clinical trial support that ranges from specialized staffing models to strategic partnerships that oversee nearly all aspects of a drug program, while the company's commercialization solutions includes outsourced sales, consulting, public relations, and advertising services.
Executives
Michael J. Bonello officer: Chief Financial Officer 4130 PARKLAKE AVENUE, SUITE 400, RALEIGH NY 27612
Stanford Rudnick officer: See remarks C/O SYNEOS HEALTH, INC., 1030 SYNC STREET, MORRISVILLE NC 27560-5468
Christian Tucat officer: Chief Business Officer C/O SYNEOS HEALTH, INC., 1030 SYNC STREET, MORRISVILLE NC 27560-5468
Michael Lee Brooks officer: See remarks C/O SYNEOS HEALTH, INC., 1030 SYNC STREET, MORRISVILLE NC 27560
Jonathan Olefson officer: General Counsel & Corp Secty C/O SYNEOS HEALTH, INC., 1030 SYNC STREET, MORRISVILLE NC 27560
Michelle Keefe officer: Pres., Commercial Solutions C/O SYNEOS HEALTH,INC., 1030 SYNC STREET, MORRISVILLE NC 27560
Jason M. Meggs officer: Chief Financial Officer C/O SYNEOS HEALTH, INC., 1030 SYNC STREET, MORRISVILLE NC 27560
Donna Hildebrand Kralowetz officer: SVP, Chief Accounting Officer C/O SYNEOS HEALTH, INC., 1030 SYNC STREET, MORRISVILLE NC 27560
Matthew E. Monaghan director ONE INVACARE WAY, ELYRIA OH 44035
Alfonso G Zulueta director 4925 INDIANA AVE, LISLE IL 60532
Barbara W. Bodem director C/O DENTSPLY SIRONA INC, 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277
Linda S Harty director MEDTRONIC PLC, 710 MEDTRONIC PARKWAY NE, LC-150, MINNEAPOLIS MN 55432
Alistair Macdonald officer: Chief Operating Officer C/O SYNEOS HEALTH, INC., 1030 SYNC STREET, MORRISVILLE NC 27560
David S. Wilkes director ONE BAXTER PARKWAY, DEERFIELD IL 60015
Advent International Corp/ma 10 percent owner 800 BOYLSTON STREET SUITE 3300, BOSTON MA 02199

Syneos Health (Syneos Health) Headlines

From GuruFocus